Sort
78,016 grants matching “breast cancer”
Proteolytic Control of Oncoprotein Function
$572,289William Patrick Tansey · Cold Spring Harbor Laboratory · P01 · FY2009 · CA
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients
$572,275Charles M Perou · Univ Of North Carolina Chapel Hill · U01 · FY2019 · CA
Predictive Modeling of the EGFR-MAPK pathway for Triple Negative Breast Cancer Patients
$572,275Charles M Perou · Univ Of North Carolina Chapel Hill · U01 · FY2021 · CA
Biomarkers for predicting response to Hsp90 therapy
$572,232Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy
$572,222Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Tissue Tension, RANK and Breast Cancer Risk
$572,212Valerie Marie Weaver · University Of California, San Francisco · R01 · FY2021 · CA
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
$572,202Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2022 · CA
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
$572,202Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2023 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
$572,160Mary L. Disis · University Of Washington · R01 · FY2010 · CA
A direct-indirect dual-layer flat-panel detector for breast cancer detection
$572,103Wei Zhao · State University New York Stony Brook · R01 · FY2024 · EB
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
$572,096Kit S Lam · University Of California At Davis · R01 · FY2021 · CA
Photon-counting X-ray and Optical Tomography for Preclinical Cancer Research
$572,090Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2022 · CA
Functional Analysis of Human Breast Cancer Susceptibility Gene Variants
$572,076Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
HTS for TGF-beta receptor assembly inhibitors with anti-tumor and anti-fibrosis activities
$572,036Andrew P Hinck · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Medications, Genetic Variability &Breast Cancer
$571,946University Of Wisconsin Madison · R01 · FY2004 · CA
Group Phone-based Weight Control among Rural Breast Cancer Survivors
$571,921Christie Befort · University Of Kansas Medical Center · R01 · FY2012 · CA
Mechanisms of Tumor Cell Dormancy and Tumor Recurrence
$571,893Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Transgenic Models for Breast Cancer
$571,893Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
GENETIC ANALYSIS OF BREAST AND OVARIAN CANCER
$571,860University Of Washington · R01 · FY2000 · CA
IDENTIFICATION OF EARLY CONTRIBUTORS TO BRCA1-MUTATION-DRIVEN BREAST CANCER
$571,849University Of Mass At Boston · · FY2017 · Department of the Army
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
$571,826Carol Ann Lange · University Of Minnesota · R01 · FY2024 · CA
BREAST CANCER--PREPARING FOR SURVIVORSHIP
$571,791University Of California Los Angeles · R01 · FY2001 · CA
RNA circuits for cell state determination in mammalian cells in vitro and in vivo
$571,770Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2019 · CA
Epigenetic Drivers of Cancer (PQ 10)
$571,757Peter W Laird · University Of Southern California · R01 · FY2014 · CA
CAREER: Probing the Physiochemical Regulators of Tumor Stroma Interactions Using Microfluidic Biomimicry
$571,753Jonathan W Song · Ohio State University, The · · FY2018 · ENG